- A 26-year-old Hispanic male presented with sudden monocular vision loss in the left eye. Examination found normal vision in the right eye but reduced vision in the left eye with retinal hemorrhage.
- Differential diagnoses included Valsalva retinopathy, papillophlebitis, retinal vasculitis, or frosted branch angiitis. Further testing found no evidence of infection, autoimmune disease, or hypercoagulability.
- Over subsequent visits, the retinal hemorrhage resolved but ischemic changes remained nasally. The appearance was consistent with a venous occlusion. Calcium deposits developed nasally resembling Kyrieleis plaques. Vision improved to normal in the left eye
Uremic Encephalopathy in End Stage Renal Disease A Case Reportijtsrd
UREMIC ENCEPHALOPATHY is an acute or sub acute organic brain syndrome that occurs in patients with advanced renal failure and is frequently associated with GFR less than 10ml min 1.73m2. Under conditions of renal failure where the blood level of urea is high. The common symptoms include sluggishness, fatigue, day time drowsiness, insomnia, slurring of speech, anorexia, myoclonus, asterixis, aphasic episode, coma and convulsion. In this case a 69 year old male patient with history of ESRD, was presented with certain neurological symptoms associated with uremic encephalopathy. This case report adds to the prevalence of uremic encephalopathy associated with end stage renal disease and the importance of hemodialysis to resolve the clinical manifestations. Becky Maria Biju | Anitha Mathew | Biji Joseph ""Uremic Encephalopathy in End Stage Renal Disease: A Case Report"" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-4 , June 2019, URL: https://www.ijtsrd.com/papers/ijtsrd23945.pdf
Paper URL: https://www.ijtsrd.com/medicine/other/23945/uremic-encephalopathy-in-end-stage-renal-disease-a-case-report/becky-maria-biju
Uremic Encephalopathy in End Stage Renal Disease A Case Reportijtsrd
UREMIC ENCEPHALOPATHY is an acute or sub acute organic brain syndrome that occurs in patients with advanced renal failure and is frequently associated with GFR less than 10ml min 1.73m2. Under conditions of renal failure where the blood level of urea is high. The common symptoms include sluggishness, fatigue, day time drowsiness, insomnia, slurring of speech, anorexia, myoclonus, asterixis, aphasic episode, coma and convulsion. In this case a 69 year old male patient with history of ESRD, was presented with certain neurological symptoms associated with uremic encephalopathy. This case report adds to the prevalence of uremic encephalopathy associated with end stage renal disease and the importance of hemodialysis to resolve the clinical manifestations. Becky Maria Biju | Anitha Mathew | Biji Joseph ""Uremic Encephalopathy in End Stage Renal Disease: A Case Report"" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-3 | Issue-4 , June 2019, URL: https://www.ijtsrd.com/papers/ijtsrd23945.pdf
Paper URL: https://www.ijtsrd.com/medicine/other/23945/uremic-encephalopathy-in-end-stage-renal-disease-a-case-report/becky-maria-biju
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. 13-5-2019 Paziente Ispanico di 26 anni maschio, si presenta in PS con
calo del visus da un giorno in OS, prima intermittente con flash e poi
dalla mattina permanente.
L’OD e’ normale.
Visus OD 10/10 nat
Visus OS 1/50 nmcl,
tono 11mmHg OO.
Anamnesi generale, oculare e familiare negativa per patologie degne di
nota.
Va tutti i giorni in Palestra.
DD: Valsalva Retinopathy, viene inviato al Chirurgo VR. Si esegue
Retinografia e OCT.
4. Valsalva Retinopathy
• Particular form of retinopathy, pre-retinal and hemorrhagic in nature,
secondary to a sudden increase in intrathoracic pressure.
• It was used to describe retinal hemorrhages in association with heavy
lifting, coughing, straining at stool, or vomiting.
• Valsalva retinopathy classically manifests as preretinal hemorrhage
secondary to rupturing of superficial retinal vessels caused by physical
exertion.
• The mechanism of a Valsalva maneuver is characterized by a sudden rise in
intrathoracic or intraabdominal pressure against a closed glottis, which
leads to a rapid rise of intravenous pressure within the eye, causing
retinal capillaries to spontaneously rupture.
6. 14-5-2019 Alla visita VR oltre quanto visibile in Retinografia si apprezza
nei quadranti superiori un aspetto vascolare ristretto, con vasi a
salsicciotto.
Il segmento anteriore e’ in quiete. Si invia per FAG, visita con esperto
Uveiti e consulto internistico.
Si esegue FAG.
8. 15-5-2019 Il paziente avverte un leggero discomfort su OS. Situazione
oculare invariata. Si consiglia solo riposo. L’esperto di uveiti pone la
seguente DD: problema vascolare tipo papilloflebite (Ipertensione,
dislipidemia, coagulopatie), problema infiammatorio (meno probabile,
Sarcoidosi, Hiv, TBC, Sifilide, MS, Bechet, Chron, PAN).
9. Papillophlebitis
• Papillophlebitis is a condition in which the clinical features of central retinal
vein occlusion (CRVO) are present but there is no history of vascular
disease.
• Papillophlebitis is characterized by painless unilateral disc edema and
hyperemia, retinal venous engorgement, and a variable extent of
intraretinal hemorrhage and macular edema in otherwise healthy adults
younger than 50 years.
• Papillophlebitis is often associated with systemic vascular disease (eg,
arterial hypertension, diabetes) or hematologic disorders.
• Corticosteroids, both systemic and periocular, are the mainstay of
treatment and are often coupled with anticoagulants such as heparin
and/or aspirin to reduce inflammation and treat any underlying
coagulopathies
10. Papillophlebitis
Q: When and for whom is thrombophilia testing appropriate?
A: Because papillophlebitis can be the first sign of an underlying
connective tissue disorder (eg, lupus, rheumatoid arthritis), young
women may benefit from a hematologic rheumatologic referral.
Screening for hypercoagulable status may include the following:
• Antiphospholipid antibodies and hyperhomocysteinemia;
• Factor V Leiden and prothrombin G20210A mutations; and
• Additional thrombotic risk factors such as pregnancy.
11. 20-5-2019 Al controllo si apprezzano 1+ cell in CA + depositi edoteliali. Il
vitreo appare limpido. Per il resto invariato.
Si instaura tp locale con Prednisolone collirio 6 al di e unguento prima di
dormire + cyclolux 2 al di.
22-5-2019 1+ cell in CA e depositi endoteliali, cellule in CV (globuli rossi,
spill over?).
Visus OS 2/10 con miglioramento dell’emorragia, che sta liberando il
centro della macula.
I vasi sembrano obliterati sia nasalmente che temporalmente, possibile
vasculite. Le arteriole sono ristrette, sembra aspetto a vasculite venosa.
12. Visita Internistica: Pz Ecuadoregno. Ultimo viaggio un anno prima. Un
anno prima negativo STD. No contatti TB. Anamnesi prossima negativa.
Anamnesi remota positiva per polmonite a 5 mesi di vita. Nega
assuzione di droghe e alcol (sociale). In un relazione fissa da 6 anni.
Esame fisico e di Laboratorio negativo
13. Visita internistica 20-5-2019
• Controles: RR 130/93, pols 62/min, Lengte: 162cm, gewicht 72kg (met kleding), BMI 27, H/H: geen lymfadenopathie in de
hals of supraclaviculair. Inspectie keel: geen roodheid, geen zwelling. Cor: S1S2, geen souffle Pulm: beiderzijds VAG zonder
bijgeluiden Abd: soepel, NP, WT, geen drukpijn, geen hepatosplemomegalie Extr: soepele kuiten, geen oedemen Geen
huidafwijkingen, behoudens enkele puistjes op de thorax. Geen afwijkingen aan de nagels.
• Laboratorium 16-06 Ureum 4.1, Kreatinine 82, natrium 142, kalium 4.3, ASAT 26, ALAT 30, LD 161, Bilirubine 9, Alk Fos 81,
Hb 10.0, Leukocyten 7.5, Trombocyten 238, Bezinking 2, CRP <1, Ferritine 131, Vit B12 323, Foliumzuur 11.4
• Conclusie: Retinabloeding links met atypisch beeld bij oogheelkundig onderzoek mogelijk passend bij vasculitis dan wel
veneus occlusie beeld DD - Cardiovasculair (HT, dyslipidemie) - Trombus bij hypercoagulabiliteit (factor V Leiden,
homocysteinemie, antifosfolipiden) - Papillophlebitis t.g.v. inflammatie, echter inflammatieparamters laag (vasculitis
ihkv M. Behcet, Crohn, PAN, sarcoïdose, MS, SLE; infectieus ihkv HIV, CMV, Syfilis, toxoplasmose, TB (Eales disease),
virale hepatitis)
• Beleid: Aanvullend lab: lipidenspectrum, HbA1c, nuchter glucose - USED + totaal eiwit, kreatinine, microalbumine -
Controle 1-2 weken met Dynamap vooraf - Te bespreken: ANA/ANCA, factor V Leiden, homocysteine, antifosfolipiden -
PM: TB, HIV, CMV, toxoplasmose screening
• 22-5-2019 Lijkt een veneus probleem (DD trombotisch danwel inflammatoir), overige is er secundair aan. - Vandaag nog
prikken: antifosfolipidensyndroom (Lupus anticoagulans, anti cardiolipine, beta-2 glycoproteine), complement (C1q, C3,
C4), ANA screening, HIV, Lues serologie - X-thorax bij nog sarcoïdose in de DD - Controle a.s. maandag reeds gepland -->
dan 24-uurs bloeddrukmeting regelen ter uitsluiting nachtelijke hypertensie - Geen antistolling, geen reden voor prikken
stollingsfactoren
14. Visita internistica 27-5-2019
Dynamap: RR 115/65 mmHg Lab: Ur 4.1 Kreat 88
Leverchemie nl Hb 10 MCV 87 T 238 L 7.5 BSE 2 INR 1.0 APTT 26 Hba1c 35
Lipiden: Cholesterol 4.6 TG 1.0 LDL 3.6
APS: beta 2 glycoproteine, cardiolipine IgM/IgG negatief. Lupus anticoagulans volgt
Complement: volgt ANA screening: < 0.5 Sarcoidose: ACE, S-IL2R volgt
Used: leuko's, eiwit, ery's negatief. MMB
HIV: negatief T.Pallidum negatief. TB quantiferon negatief.
X-Thorax: Normale thorax. Geen aanwijzing voor sarcoïdose.
Conclusie: - Cardiovasculair DD Hypertensie. Geen dislypidemie (LDL 3.6) > 24u BD meting volgt
DD Trombus bij hypercoagulabiliteit ikv factor V Leiden, homocysteinemie, antifosfolipiden >cardiolipine, betaglycoproteine neg, lupus anticoagulans volgt
- Retinale vasculitis, echter BSE laag (2) DD auto-immuun mgk ihkv M. Behcet, Crohn, PAN, sarcoïdose, MS, SLE, GCA
> ANA negatief > s-IL2R/ACE volgt > complement volgt
DD infectieus, mgk ihkv CMV, Toxoplasmose, HSV/VZV, CMV). > HIV/Lues/ TB serologie negatief
Beleid - 24u bloeddrukmeting ter uitsluiting nachtelijke hypertensie PM volgende keer dieetadvies (LDL 3.6)
PM nog FVL en homocysteine bepalen? --> iom Soonwala, niet nodig, gezien geen behandelconsequenties (geen zin om antistolling te starten)
15. 27-5-2019 Visita Oculistica con FAG: nasalmente si apprezza ischemia,
ma l’area e’ ancora coperta dal sangue. Aspetto a Frosted Branch
Arteritis (che pero’prende sia vene che arterie)? In CA le cellule sono
diminuite. Tp steroidea locale a scalare.
17. Frosted Branch Angiitis
• Usually bilateral
• Specific Syndrome (primary form): rare, children or young adults
• Common immune pathway in responde to multiple infective agents:
CMV retinitis.
• Oher conditions suchs glomerulonefritis and CRVO
18. Frosted Branch Angiitis
Visual Acuity usually very poor
Florid translucent retinal perivascular
sheating of both arteriooles and venules
Anterior uveitis, vitritis and retinal oedema
Papillitis, hard exudates, retinal hemorrhages
and venous occulsion
TP is with steroid.
19. 28-5-2019 Consulto con collega dell’Universita’ di Leiden: sospetta
Valsalva in un caso di Retinopatia Purtscher che tuttavia da’ una
problematica di solito a livello del polo posteriore, qui il problema e’
nasale (papillo flebite/crvo).
20. Purtscher Retinopathy
• Purtscher retinopathy is a hemorrhagic and vasoocclusive
vasculopathy, which, was first described as a syndrome of sudden
blindness associated with severe head trauma. These patients had
findings of multiple white retinal patches and retinal hemorrhages
that were associated with severe vision loss.
• Purtscher (and Purtscher like) retinopathy has been associated with
traumatic injury, primarily blunt thoracic trauma and head trauma,
and numerous nontraumatic diseases.
21. DD of Purtscher
Retinopathy
• Acute Pancreatitis;
• fat embolization;
• amniotic fluid embolization;
• preeclampsia;
• hemolysis, elevated liver enzymes, and
low platelets (HELLP) syndrome;
• and vasculitic diseases, such as lupus.
Patients with known vasculitic disease
(eg, systemic lupus erythematosus,
scleroderma, dermatomyositis) are at risk
for developing a Purtscher-like
retinopathy with microvascular
occlusion
22. Pathophysiology of Purtsher Retinopathy
• These lesions are known as Purtscher flecken (larger infarcts of the
retinal capillary bed) and cotton-wool spots (small retinal
microinfarcts at the level of the nerve fiber layer).
• Fluorescein leakage in Purtscher retinopathy suggests that an acute
endothelial cell injury is caused by trauma, possibly predisposing
the retinal vessels to occlusion
23. Pathophysiology of Purtsher Retinopathy
• The condition has been associated with various vasculopathies.
• The most accepted mechanism is leukoembolization that causes
arterial occlusion and infarction of the microvascular bed.
• Other possible sources of emboli include fat emboli, amniotic fluid,
air emboli, and granulocyte aggregation resulting from complement
activation.
24. Pathophysiology of Purtscher Retinopathy
• Other proposed mechanisms of vascular occlusion include angiospasm
resulting from an acute rise in venous pressure from compressive chest
injuries or possibly acute head injuries and endothelial cell damage
resulting from acutely increased intraluminal pressure.
• Valsalva Retinopathy Pathophysiology:
1. a sudden increase in intrathoracic pressure decreases venous return to the right
side of the heart.
2. diminished cardiac filling lowers the mean arterial pressure, slowing the pulse,
leading to reflex tachycardia and peripheral vasoconstriction.
3. release of the strain causes a prompt reduction in the intrathoracic pressure,
further lowering the blood pressure and simultaneously increasing the cardiac
pressure.
4. an abrupt increase in blood pressure occurs as venous blood surges back to the
heart, inducing reflex bradycardia.
25. Related Conditions
Related Conditions and Diseases
• Multifocal Chororidopathy Syndromes ;
• Retinal Artery Occlusion;
• Neuroophthalmic manifestations of
vascular eye diseases;
• Hemoglobinopathy Retinopathy
• Eales Disease
• Hiv Retinopathy
• Drug Induced
• Hypertension…
26. 6-6-2019
OD aspetto retinico normale, le vene sembrano un poco congeste.
OS Il sangue continua a riassorbirsi. Nasalmente si apprezza ischemia,
l’aspetto e’ quello di una occlusione venosa di branca. Aspetto a Frosted
Branch Arteritis.
Tp steroidea locale sospesa.
29-6-2019
OS l’emorragia maculare si é completamente riassorbita, il visus
e’risalito a 10/10. Nasalmente si apprezza ischemia.
27. 11-08-2019
Va tutto bene, i sintomi sono completamente rientrati, il visus e’ 10/10.
Al fondo l’ OD e’ normale con leggera congestione venosa.
In OS il polo posteriore e’ praticamente normale, al livello della papilla
un piccolo tuft emorragico e vasi fantasma. Nasalmente si apprezzano
emorragie preretiniche.
I vasi nasalmente presentano come delle calcificazioni biancastre al loro
interno tipo: Kyrieleis Plaques
29. Kyrieleis Plaques
Kyrieleis plaques are segmental
periarteriolar inflammatory plaques that
occur in various diseases such as toxoplasma
retinochoroiditis, cytomegalovirus retinitis,
and Susac syndrome
Although first described as of part of a
Tubercolosis related retinitis by Dr Werner
Kyrieleis, calcific plaques on the walls of
blood vessels, have become associated with
toxoplasmosis retinitis.
Labo in our patients shows however IgG + for
Toxo but not IgM
DD SLE, PAN, Lues, HSV, VZV, IRVAN, Churg
Strauss syndr, Sarcoidose, relapsing
polychrondritis, Wegener, Crohn, Frosted
branch angiitis
30. 30-08-2019
Continuiamo a pensare a una Toxo, l’unica lesione che ce lo fa supporre
e’una area depigmentata sotto la papilla correlata tra l’altro a un difetto
superiore del CV.
Pensiamo di fare un puntura in CA per PCR toxo e Herpes ma ci viene
sconsigliata dai colleghi piu’ esperti dell’universita’ di Leiden.
33. 20-09-2019
Il paziente non ha piu’ sintomi, e’ contento ma non abbiamo una
diagnosi.
IL 6 Novembre e’ programmato per un argon laser della zona ischemica
paranasale.
L’ipotesi piu’ probabile e’ una Periflebite su base infiammatoria o
vascolare (es Eales Disease in assenza di TB, Toxo, Herpes, Occlusione
venosa) oppure danno microvascolare da rialzo acuto di pressione
dovuto al sollevamento pesi, tipo Retinopatia di Purtscher, complicato
da una Maculopatia Valsalva.